Novel 99mTc-Labeled Glucose Derivative for Single Photon Emission Computed Tomography: A Promising Tumor Imaging Agent

Mol Pharm. 2018 Aug 6;15(8):3417-3424. doi: 10.1021/acs.molpharmaceut.8b00415. Epub 2018 Jul 19.

Abstract

In this study, a d-glucosamine derivative with an isonitrile group (CN5DG) was synthesized and it was chosen to coordinate with 99mTc for preparing 99mTc-CN5DG. 99mTc-CN5DG could be readily obtained with high radiochemical purity (>95%) and had great in vitro stability and metabolic stability in urine. The radiotracer demonstrated a positive response to the administration of glucose and insulin in S180 and A549 tumor cells in vitro, suggesting the mechanism of 99mTc-CN5DG into tumor cells was related to glucose transporters. Biodistribution studies in mice bearing A549 xenografts showed 99mTc-CN5DG had a high tumor uptake and high tumor-to-background ratios. SPECT/CT images further supported its ability for tumor imaging. As a cheap, conveniently made and widely available probe, 99mTc-CN5DG would become a potential "working horse" and be a breakthrough in 99mTc-labeled radiopharmaceuticals for tumor detection.

Keywords: SPECT; Tc-99m; glucosamine-derivate; isonitrile; tumor imaging.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • A549 Cells
  • Animals
  • Female
  • Glucosamine / administration & dosage*
  • Glucosamine / chemistry
  • Glucosamine / pharmacokinetics
  • Humans
  • Mice
  • Neoplasms / diagnostic imaging*
  • Neoplasms / pathology
  • Organotechnetium Compounds / administration & dosage*
  • Organotechnetium Compounds / chemistry
  • Organotechnetium Compounds / pharmacokinetics
  • Technetium / administration & dosage*
  • Technetium / chemistry
  • Technetium / pharmacokinetics
  • Tissue Distribution
  • Tomography, Emission-Computed, Single-Photon / methods*
  • Xenograft Model Antitumor Assays

Substances

  • Organotechnetium Compounds
  • Technetium
  • Glucosamine